According to recently ran experiments, cannabis can be considered an effective remedy for patients diagnosed with multiple sclerosis. While initially the symptomatic improvements experienced by patients with multiple sclerosis who have been researched cannabinoid products were thought to be determined solely by psychological things, after research has demonstrated that cannabis actually reduces muscular stiffness and stiffness feature into multiple sclerosis patients. The benefic effects of cannabis on patients with multiple sclerosis have been confirmed by short-term and long-term controlled clinical trials.
The previously conducted studies included the active participation of around 600 patients having advanced-stage multiple sclerosis. By the close of the experiment, the majority of patients that were treated cannabinoids experienced considerable symptomatic improvements, with less muscle pain and being confronted with milder muscular spasticity (less conspicuous muscle strain ). Unlike the group who received cannabinoid chemicals over the entire period of the analysis, the control group (patients who received placebo medications) undergone no improvements in their overall illness.https://www.trythecbd.com
So as to confirm the significance of their findings and also to lose any doubts in regards to the efficiency of cannabis at ameliorating the signs of multiple sclerosis, the study was later replicated. The ulterior analysis was conducted within a span of 12 months, also involved the involvement of the very same subjects. But this period the participants were divided into 3 distinctive groups rather than 2 as in case of the former experiment. The first group received pills of D9-tetrahydrocannabinol (THC) – the most active component in cannabisthat the second group received natural cannabis extracts, as the third group received placebo medications.
At the end of the experiment, both patients were closely evaluated and carefully examined by a team of physiotherapists and neurologists. The most effective results were obtained among the patients from this first study group, a clear majority of subjects who’ve received equal doses of THC experiencing considerable improvements in their symptoms. The patients at the next study group experienced slight improvements in their symptoms, while the patients in the third group believed no changes in their condition.